<?xml version="1.0" encoding="UTF-8" standalone="no"?>

<MINiML
   xmlns="http://www.ncbi.nlm.nih.gov/geo/info/MINiML"
   xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
   xsi:schemaLocation="http://www.ncbi.nlm.nih.gov/geo/info/MINiML http://www.ncbi.nlm.nih.gov/geo/info/MINiML.xsd"
   version="0.5.0" >

  <Contributor iid="contrib1">
    <Person><First>Hector</First><Middle>R</Middle><Last>Wong</Last></Person>
    <Email>hector.wong@cchmc.org</Email>
    <Phone>513-636-4259</Phone>
    <Fax>513-636-4267</Fax>
    <Department>Division of Critical Care Medicine</Department>
    <Organization>CIncinnati Children's Hospital Medical Center</Organization>
    <Address>
      <Line>3333 Burnet Ave</Line>
      <City>Cincinnati</City>
      <State>OH</State>
      <Zip-Code>45229-3039</Zip-Code>
      <Country>USA</Country>
    </Address>
  </Contributor>

  <Contributor iid="contrib2">
    <Organization></Organization>
    <Email>geo@ncbi.nlm.nih.gov, support@affymetrix.com</Email>
    <Phone>888-362-2447</Phone>
    <Organization>Affymetrix, Inc.</Organization>
    <Address>
      <City>Santa Clara</City>
      <State>CA</State>
      <Zip-Code>95051</Zip-Code>
      <Country>USA</Country>
    </Address>
    <Web-Link>http://www.affymetrix.com/index.affx</Web-Link>
  </Contributor>

  <Contributor iid="contrib3">
    <Person><First>Natalie</First><Last>Cvijanovich</Last></Person>
  </Contributor>

  <Contributor iid="contrib4">
    <Person><First>Geoffrey</First><Middle>L</Middle><Last>Allen</Last></Person>
  </Contributor>

  <Contributor iid="contrib5">
    <Person><First>Richard</First><Last>Lin</Last></Person>
  </Contributor>

  <Contributor iid="contrib6">
    <Person><First>Nick</First><Last>Anas</Last></Person>
  </Contributor>

  <Contributor iid="contrib7">
    <Person><First>Keith</First><Last>Meyer</Last></Person>
  </Contributor>

  <Contributor iid="contrib8">
    <Person><First>Robert</First><Middle>J</Middle><Last>Freishtat</Last></Person>
  </Contributor>

  <Contributor iid="contrib9">
    <Person><First>Marie</First><Last>Monaco</Last></Person>
  </Contributor>

  <Contributor iid="contrib10">
    <Person><First>Kelli</First><Last>Odoms</Last></Person>
  </Contributor>

  <Contributor iid="contrib11">
    <Person><First>Bhuvaneswari</First><Last>Sakthivel</Last></Person>
  </Contributor>

  <Contributor iid="contrib12">
    <Person><First>Thomas</First><Middle>P</Middle><Last>Shanley</Last></Person>
  </Contributor>

  <Database iid="GEO">
    <Name>Gene Expression Omnibus (GEO)</Name>
    <Public-ID>GEO</Public-ID>
    <Organization>NCBI NLM NIH</Organization>
    <Web-Link>http://www.ncbi.nlm.nih.gov/geo</Web-Link>
    <Email>geo@ncbi.nlm.nih.gov</Email>
  </Database>

  <Platform iid="GPL570">
    <Status database="GEO">
      <Submission-Date>2003-11-07</Submission-Date>
      <Release-Date>2003-11-07</Release-Date>
      <Last-Update-Date>2019-03-25</Last-Update-Date>
    </Status>
    <Title>[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array</Title>
    <Accession database="GEO">GPL570</Accession>
    <Technology>in situ oligonucleotide</Technology>
    <Distribution>commercial</Distribution>
    <Organism taxid="9606">Homo sapiens</Organism>
    <Manufacturer>Affymetrix</Manufacturer>
    <Manufacture-Protocol>
see manufacturer's web site

Complete coverage of the Human Genome U133 Set plus 6,500 additional genes for analysis of over 47,000 transcripts
All probe sets represented on the GeneChip Human Genome U133 Set are identically replicated on the GeneChip Human Genome U133 Plus 2.0 Array. The sequences from which these probe sets were derived were selected from GenBank®, dbEST, and RefSeq. The sequence clusters were created from the UniGene database (Build 133, April 20, 2001) and then refined by analysis and comparison with a number of other publicly available databases, including the Washington University EST trace repository and the University of California, Santa Cruz Golden-Path human genome database (April 2001 release).
In addition, there are 9,921 new probe sets representing approximately 6,500 new genes. These gene sequences were selected from GenBank, dbEST, and RefSeq. Sequence clusters were created from the UniGene database (Build 159, January 25, 2003) and refined by analysis and comparison with a number of other publicly available databases, including the Washington University EST trace repository and the NCBI human genome assembly (Build 31).

    </Manufacture-Protocol>
    <Description>
Affymetrix submissions are typically submitted to GEO using the GEOarchive method described at http://www.ncbi.nlm.nih.gov/projects/geo/info/geo_affy.html

June 03, 2009: annotation table updated with netaffx build 28
June 06, 2012: annotation table updated with netaffx build 32
June 23, 2016: annotation table updated with netaffx build 35
    </Description>
    <Web-Link>http://www.affymetrix.com/support/technical/byproduct.affx?product=hg-u133-plus</Web-Link>
    <Web-Link>http://www.affymetrix.com/analysis/index.affx</Web-Link>
    <Relation type="Alternative to" target="GPL4454" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL4866" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL5760" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL6671" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL6791" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL6879" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL7567" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL8019" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL8542" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL8715" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL8712" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9102" comment="Probe Level Version" />
    <Relation type="Alternative to" target="GPL9099" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9101" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9324" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9486" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9987" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10175" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10335" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10371" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10526" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10881" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10925" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL11084" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL11433" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL11670" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL13232" comment="Alternative CDF [HGU133Plus2_Hs_REFSEQ, Brainarray version 13.0.0]" />
    <Relation type="Alternative to" target="GPL13303" comment="Alternative CDF." />
    <Relation type="Alternative to" target="GPL13916" comment="[Brainarray ENSG Version 14.1]" />
    <Relation type="Alternative to" target="GPL14837" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL14877" comment="[Alternative CDF]" />
    <Relation type="Alternative to" target="GPL15394" comment="Alternative CDF [HGU133Plus2_Hs_REFSEQ, Brainarray version 14.0]" />
    <Relation type="Alternative to" target="GPL6732" comment="Alternative CDF [HGU133Plus2_Hs_REFSEQ, Brainarray version 7]" />
    <Relation type="Alternative to" target="GPL15445" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL16066" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL16100" comment="Alternative CDF [GATExplorer_Ensembl v57]" />
    <Relation type="Alternative to" target="GPL16268" comment="Alternative CDF [Brainarray ENSG Version 16]" />
    <Relation type="Alternative to" target="GPL16273" comment="Alternative CDF [Brainarray ENSG Version 15]" />
    <Relation type="Alternative to" target="GPL16311" comment="Alternative CDF [HGU133Plus2_Hs_ENTREZG Brainarray version 14.0.0]" />
    <Relation type="Alternative to" target="GPL16356" comment="Alternative CDF [Brainarray HGU133Plus2_Hs_ENTREZG 15.0.0]" />
    <Relation type="Alternative to" target="GPL16372" comment="Alternative CDF [Brainarray HGU133Plus2_Hs_UG v.13]" />
    <Relation type="Alternative to" target="GPL17392" comment="Alternative CDF [HGU133Plus2_Hs_ENSG, Brainarray 17.1]" />
    <Relation type="Alternative to" target="GPL17394" comment="Alternative CDF [HGU133Plus2_Hs_ENSG, Brainarray 13.0]" />
    <Relation type="Alternative to" target="GPL17810" comment="Alternative CDF [HGU133Plus2_Hs_ENTREZG, Brainarray 16]" />
    <Relation type="Alternative to" target="GPL17811" comment="Alternative CDF [HGU133Plus2_Hs_ENTREZG, Brainarray 17]" />
    <Relation type="Alternative to" target="GPL17996" comment="Alternative CDF:HGU133Plus2_Hs_ENTREZG.cdf version 15.1.0" />
    <Relation type="Alternative to" target="GPL18121" comment="custom CDF" />
    <Relation type="Alternative to: GPL18756 (Alternative CDF [CDF" target="HGU133Plus2_Hs_ENTREZG_14.1.0])" />
    <Relation type="Alternative to" target="GPL18850" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL18478" comment="Alternative CDF [Hs_ENTREZG_V13]" />
    <Relation type="Alternative to" target="GPL19109" comment="Alternative CDF [Brainarray HGU133Plus2_Hs_ENTREZG_v18]" />
    <Relation type="Alternative to" target="GPL19883" comment="Alternative CDF [Broad GenePattern]" />
    <Relation type="Alternative to" target="GPL19918" comment="Gene symbol version, 10K" />
    <Relation type="Alternative to" target="GPL20182" comment="Gene Symbol Version" />
    <Relation type="Alternative to" target="GPL22321" comment="Alternative CDF [HGU133Plus2_Hs_ENTREZG, Brainarray 20]" />
    <Relation type="Alternative to" target="GPL22945" comment="alternative" />
    <Relation type="Alternative to" target="GPL23270" comment="(Alternative CDF [HGU133Plus2_Hs_ENTREZG, Brainarray 21]" />
    <Relation type="Alternative to" target="GPL23432" comment="alternative CDF [HGU133Plus2_Hs_ENSG, Brainarray version 18.0.0]" />
    <Relation type="Alternative to" target="GPL25740" comment="alternative" />
    <Data-Table>
      <Column position="1">
        <Name>ID</Name>
        <Description>Affymetrix Probe Set ID </Description>
        <Link-Prefix>https://www.affymetrix.com/LinkServlet?array=U133PLUS&amp;probeset=</Link-Prefix>
      </Column>
      <Column position="2">
        <Name>GB_ACC</Name>
        <Description>GenBank Accession Number </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/nuccore/?term=</Link-Prefix>
      </Column>
      <Column position="3">
        <Name>SPOT_ID</Name>
        <Description>identifies controls</Description>
      </Column>
      <Column position="4">
        <Name>Species Scientific Name</Name>
        <Description>The genus and species of the organism represented by the probe set.</Description>
      </Column>
      <Column position="5">
        <Name>Annotation Date</Name>
        <Description>The date that the annotations for this probe array were last updated. It will generally be earlier than the date when the annotations were posted on the Affymetrix web site.</Description>
      </Column>
      <Column position="6">
        <Name>Sequence Type</Name>
      </Column>
      <Column position="7">
        <Name>Sequence Source</Name>
        <Description>The database from which the sequence used to design this probe set was taken.</Description>
      </Column>
      <Column position="8">
        <Name>Target Description</Name>
      </Column>
      <Column position="9">
        <Name>Representative Public ID</Name>
        <Description>The accession number of a representative sequence. Note that for consensus-based probe sets, the representative sequence is only one of several sequences (sequence sub-clusters) used to build the consensus sequence and it is not directly used to derive the probe sequences. The representative sequence is chosen during array design as a sequence that is best associated with the transcribed region being interrogated by the probe set. Refer to the &quot;Sequence Source&quot; field to determine the database used.</Description>
      </Column>
      <Column position="10">
        <Name>Gene Title</Name>
        <Description>Title of Gene represented by the probe set.</Description>
      </Column>
      <Column position="11">
        <Name>Gene Symbol</Name>
        <Description>A gene symbol, when one is available (from UniGene).</Description>
      </Column>
      <Column position="12">
        <Name>ENTREZ_GENE_ID</Name>
        <Description>Entrez Gene Database UID  </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/gene/</Link-Prefix>
        <Link-Delimiter> /// </Link-Delimiter>
      </Column>
      <Column position="13">
        <Name>RefSeq Transcript ID</Name>
        <Description>References to multiple sequences in RefSeq. The field contains the ID and Description for each entry, and there can be multiple entries per ProbeSet.</Description>
      </Column>
      <Column position="14">
        <Name>Gene Ontology Biological Process</Name>
        <Description>Gene Ontology Consortium Biological Process derived from LocusLink.  Each annotation consists of three parts: &quot;Accession Number // Description // Evidence&quot;. The description corresponds directly to the GO ID. The evidence can be &quot;direct&quot;, or &quot;extended&quot;.</Description>
      </Column>
      <Column position="15">
        <Name>Gene Ontology Cellular Component</Name>
        <Description>Gene Ontology Consortium Cellular Component derived from LocusLink.  Each annotation consists of three parts: &quot;Accession Number // Description // Evidence&quot;. The description corresponds directly to the GO ID. The evidence can be &quot;direct&quot;, or &quot;extended&quot;.</Description>
      </Column>
      <Column position="16">
        <Name>Gene Ontology Molecular Function</Name>
        <Description>Gene Ontology Consortium Molecular Function derived from LocusLink.  Each annotation consists of three parts: &quot;Accession Number // Description // Evidence&quot;. The description corresponds directly to the GO ID. The evidence can be &quot;direct&quot;, or &quot;extended&quot;.</Description>
      </Column>
    <External-Data rows="54675">
GPL570-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Platform>

  <Sample iid="GSM350139">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>04-0011C_Control_day1_66</Title>
    <Accession database="GEO">GSM350139</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350139/suppl/GSM350139.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617594" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350139-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350140">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>04-0010C_Control_day1_72</Title>
    <Accession database="GEO">GSM350140</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350140/suppl/GSM350140.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617595" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350140-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350141">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0052C_Control_day1_135</Title>
    <Accession database="GEO">GSM350141</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350141/suppl/GSM350141.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617596" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350141-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350142">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0008_Control_day1_146</Title>
    <Accession database="GEO">GSM350142</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350142/suppl/GSM350142.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350142-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350143">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0009_Control_day1_147</Title>
    <Accession database="GEO">GSM350143</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350143/suppl/GSM350143.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350143-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350144">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0011_Control_day1_149</Title>
    <Accession database="GEO">GSM350144</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350144/suppl/GSM350144.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350144-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350145">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0012_Control_day1_150</Title>
    <Accession database="GEO">GSM350145</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350145/suppl/GSM350145.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350145-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350146">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0013_Control_day1_151</Title>
    <Accession database="GEO">GSM350146</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350146/suppl/GSM350146.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350146-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350147">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0014_Control_day1_152</Title>
    <Accession database="GEO">GSM350147</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350147/suppl/GSM350147.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350147-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350148">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0018_Control_day1_159</Title>
    <Accession database="GEO">GSM350148</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350148/suppl/GSM350148.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350148-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350149">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0019_Control_day1_160</Title>
    <Accession database="GEO">GSM350149</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350149/suppl/GSM350149.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350149-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350150">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0020_Control_day1_161</Title>
    <Accession database="GEO">GSM350150</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350150/suppl/GSM350150.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350150-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350151">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0027_Control_day1_167</Title>
    <Accession database="GEO">GSM350151</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350151/suppl/GSM350151.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350151-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350152">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0037_Control_day1_173</Title>
    <Accession database="GEO">GSM350152</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350152/suppl/GSM350152.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350152-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350153">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>15-0001_Control_day1_204</Title>
    <Accession database="GEO">GSM350153</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350153/suppl/GSM350153.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350153-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350154">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>15-0002_Control_day1_205</Title>
    <Accession database="GEO">GSM350154</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350154/suppl/GSM350154.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350154-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350155">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>15-0003_Control_day1_206</Title>
    <Accession database="GEO">GSM350155</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350155/suppl/GSM350155.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350155-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350156">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>15-0005_Control_day1_209</Title>
    <Accession database="GEO">GSM350156</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Control_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350156/suppl/GSM350156.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350156-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350157">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0039A_SIRS_day1_5</Title>
    <Accession database="GEO">GSM350157</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350157/suppl/GSM350157.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617597" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350157-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350158">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2015-02-23</Last-Update-Date>
    </Status>
    <Title>01-0063A_SIRS_day1_19</Title>
    <Accession database="GEO">GSM350158</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350158/suppl/GSM350158.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617598" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350158-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350159">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0037A_SIRS_day1_41</Title>
    <Accession database="GEO">GSM350159</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350159/suppl/GSM350159.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617599" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350159-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350160">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>04-0008A_SIRS_day1_71</Title>
    <Accession database="GEO">GSM350160</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350160/suppl/GSM350160.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617600" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350160-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350161">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>06-0002_SIRS_day1_87</Title>
    <Accession database="GEO">GSM350161</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350161/suppl/GSM350161.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350161-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350162">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0022A_SIRS_day1_105</Title>
    <Accession database="GEO">GSM350162</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350162/suppl/GSM350162.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617601" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350162-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350163">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0023A_SIRS_day1_106</Title>
    <Accession database="GEO">GSM350163</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350163/suppl/GSM350163.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617602" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350163-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350164">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>10-0029A_SIRS_day1_108</Title>
    <Accession database="GEO">GSM350164</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350164/suppl/GSM350164.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350164-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350165">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0006_SIRS_day1_114</Title>
    <Accession database="GEO">GSM350165</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350165/suppl/GSM350165.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350165-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350166">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0040A_SIRS_day1_129</Title>
    <Accession database="GEO">GSM350166</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350166/suppl/GSM350166.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617603" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350166-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350167">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0049A_SIRS_day1_132</Title>
    <Accession database="GEO">GSM350167</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350167/suppl/GSM350167.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617604" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350167-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350168">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0051A_SIRS_day1_133</Title>
    <Accession database="GEO">GSM350168</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350168/suppl/GSM350168.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617605" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350168-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350169">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0015_SIRS_day1_153</Title>
    <Accession database="GEO">GSM350169</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350169/suppl/GSM350169.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350169-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350170">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0016_SIRS_day1_155</Title>
    <Accession database="GEO">GSM350170</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350170/suppl/GSM350170.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617606" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350170-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350171">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0031_SIRS_day1_170</Title>
    <Accession database="GEO">GSM350171</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350171/suppl/GSM350171.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350171-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350172">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0036_SIRS_day1_171</Title>
    <Accession database="GEO">GSM350172</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350172/suppl/GSM350172.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350172-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350173">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0045A_SIRS_day1_176</Title>
    <Accession database="GEO">GSM350173</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350173/suppl/GSM350173.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617607" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350173-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350174">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0046A_SIRS_day1_178</Title>
    <Accession database="GEO">GSM350174</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350174/suppl/GSM350174.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617608" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350174-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350175">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0059A_SIRS_day1_185</Title>
    <Accession database="GEO">GSM350175</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350175/suppl/GSM350175.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617609" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350175-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350176">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0060A_SIRS_day1_187</Title>
    <Accession database="GEO">GSM350176</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350176/suppl/GSM350176.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617610" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350176-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350177">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>14-0001A_SIRS_day1_193</Title>
    <Accession database="GEO">GSM350177</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350177/suppl/GSM350177.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617611" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350177-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350178">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>15-0010A_SIRS_day1_199</Title>
    <Accession database="GEO">GSM350178</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350178/suppl/GSM350178.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617612" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350178-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350179">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0029B_SIRS_day3_109</Title>
    <Accession database="GEO">GSM350179</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350179/suppl/GSM350179.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350179-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350180">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0006_SIRS_day3_115</Title>
    <Accession database="GEO">GSM350180</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350180/suppl/GSM350180.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350180-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350181">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0036_SIRS_day3_172</Title>
    <Accession database="GEO">GSM350181</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350181/suppl/GSM350181.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350181-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350182">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>15-0010B_SIRS_day3_200</Title>
    <Accession database="GEO">GSM350182</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350182/suppl/GSM350182.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350182-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350183">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>25-070603_SIRS_day3_221</Title>
    <Accession database="GEO">GSM350183</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350183/suppl/GSM350183.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350183-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350184">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0039B_SIRS resolved_day3_6</Title>
    <Accession database="GEO">GSM350184</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350184/suppl/GSM350184.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350184-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350185">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0043B_SIRS resolved_day3_8</Title>
    <Accession database="GEO">GSM350185</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350185/suppl/GSM350185.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350185-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350186">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0059B_SIRS resolved_day3_13</Title>
    <Accession database="GEO">GSM350186</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350186/suppl/GSM350186.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350186-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350187">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0063B_SIRS resolved_day3_20</Title>
    <Accession database="GEO">GSM350187</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350187/suppl/GSM350187.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350187-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350188">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0024_SIRS resolved_day3_30</Title>
    <Accession database="GEO">GSM350188</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350188/suppl/GSM350188.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350188-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350189">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0026_SIRS resolved_day3_34</Title>
    <Accession database="GEO">GSM350189</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350189/suppl/GSM350189.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350189-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350190">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0027_SIRS resolved_day3_36</Title>
    <Accession database="GEO">GSM350190</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350190/suppl/GSM350190.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350190-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350191">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0048B_SIRS resolved_day3_46</Title>
    <Accession database="GEO">GSM350191</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350191/suppl/GSM350191.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350191-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350192">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>02-0001_SIRS resolved_day3_60</Title>
    <Accession database="GEO">GSM350192</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350192/suppl/GSM350192.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350192-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350193">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>05-0008_SIRS resolved_day3_78</Title>
    <Accession database="GEO">GSM350193</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350193/suppl/GSM350193.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350193-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350194">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>06-0001_SIRS resolved_day3_86</Title>
    <Accession database="GEO">GSM350194</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350194/suppl/GSM350194.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350194-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350195">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>07-0002_SIRS resolved_day3_96</Title>
    <Accession database="GEO">GSM350195</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350195/suppl/GSM350195.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350195-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350196">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0007_SIRS resolved_day3_117</Title>
    <Accession database="GEO">GSM350196</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350196/suppl/GSM350196.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350196-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350197">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0051B_SIRS resolved_day3_134</Title>
    <Accession database="GEO">GSM350197</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350197/suppl/GSM350197.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350197-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350198">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0058B_SIRS resolved_day3_140</Title>
    <Accession database="GEO">GSM350198</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350198/suppl/GSM350198.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350198-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350199">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0060B_SIRS resolved_day3_141</Title>
    <Accession database="GEO">GSM350199</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350199/suppl/GSM350199.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350199-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350200">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0001_SIRS resolved_day3_143</Title>
    <Accession database="GEO">GSM350200</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350200/suppl/GSM350200.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350200-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350201">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0016_SIRS resolved_day3_156</Title>
    <Accession database="GEO">GSM350201</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350201/suppl/GSM350201.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350201-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350202">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0045B_SIRS resolved_day3_177</Title>
    <Accession database="GEO">GSM350202</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350202/suppl/GSM350202.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350202-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350203">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0049B_SIRS resolved_day3_179</Title>
    <Accession database="GEO">GSM350203</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350203/suppl/GSM350203.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350203-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350204">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0059B_SIRS resolved_day3_186</Title>
    <Accession database="GEO">GSM350204</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350204/suppl/GSM350204.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350204-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350205">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>14-0001B_SIRS resolved_day3_194</Title>
    <Accession database="GEO">GSM350205</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350205/suppl/GSM350205.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350205-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350206">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0006_SIRS resolved_day3_198</Title>
    <Accession database="GEO">GSM350206</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350206/suppl/GSM350206.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350206-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350207">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0002_SIRS resolved_day3_225</Title>
    <Accession database="GEO">GSM350207</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>SIRS resolved_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350207/suppl/GSM350207.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350207-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350208">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0038A_Sepsis_day1_4</Title>
    <Accession database="GEO">GSM350208</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350208/suppl/GSM350208.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617613" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350208-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350209">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0043A_Sepsis_day1_7</Title>
    <Accession database="GEO">GSM350209</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350209/suppl/GSM350209.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350209-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350210">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0027_Sepsis_day1_35</Title>
    <Accession database="GEO">GSM350210</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350210/suppl/GSM350210.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350210-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350211">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0046A_Sepsis_day1_45</Title>
    <Accession database="GEO">GSM350211</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350211/suppl/GSM350211.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617614" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350211-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350212">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0055A_Sepsis_day1_57</Title>
    <Accession database="GEO">GSM350212</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350212/suppl/GSM350212.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617615" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350212-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350213">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>03-0001A_Sepsis_day1_64</Title>
    <Accession database="GEO">GSM350213</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350213/suppl/GSM350213.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617616" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350213-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350214">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>04-0007A_Sepsis_day1_65</Title>
    <Accession database="GEO">GSM350214</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350214/suppl/GSM350214.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617617" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350214-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350215">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>05-0002_Sepsis_day1_73</Title>
    <Accession database="GEO">GSM350215</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350215/suppl/GSM350215.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350215-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350216">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>07-0005_Sepsis_day1_97</Title>
    <Accession database="GEO">GSM350216</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350216/suppl/GSM350216.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617618" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350216-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350217">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0027A_Sepsis_day1_107</Title>
    <Accession database="GEO">GSM350217</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350217/suppl/GSM350217.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617619" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350217-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350218">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>10-0004_Sepsis_day1_111</Title>
    <Accession database="GEO">GSM350218</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350218/suppl/GSM350218.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350218-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350219">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0005_Sepsis_day1_113</Title>
    <Accession database="GEO">GSM350219</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350219/suppl/GSM350219.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350219-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350220">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0007_Sepsis_day1_116</Title>
    <Accession database="GEO">GSM350220</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350220/suppl/GSM350220.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350220-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350221">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0010_Sepsis_day1_118</Title>
    <Accession database="GEO">GSM350221</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350221/suppl/GSM350221.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350221-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350222">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0015_Sepsis_day1_123</Title>
    <Accession database="GEO">GSM350222</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350222/suppl/GSM350222.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350222-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350223">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0041A_Sepsis_day1_130</Title>
    <Accession database="GEO">GSM350223</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350223/suppl/GSM350223.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617620" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350223-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350224">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0047A_Sepsis_day1_131</Title>
    <Accession database="GEO">GSM350224</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350224/suppl/GSM350224.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617621" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350224-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350225">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0053A_Sepsis_day1_136</Title>
    <Accession database="GEO">GSM350225</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350225/suppl/GSM350225.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617622" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350225-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350226">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0055A_Sepsis_day1_137</Title>
    <Accession database="GEO">GSM350226</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350226/suppl/GSM350226.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617623" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350226-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350227">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0003_Sepsis_day1_144</Title>
    <Accession database="GEO">GSM350227</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350227/suppl/GSM350227.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350227-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350228">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0004_Sepsis_day1_145</Title>
    <Accession database="GEO">GSM350228</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350228/suppl/GSM350228.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350228-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350229">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0021_Sepsis_day1_162</Title>
    <Accession database="GEO">GSM350229</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350229/suppl/GSM350229.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617624" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350229-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350230">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0022_Sepsis_day1_164</Title>
    <Accession database="GEO">GSM350230</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350230/suppl/GSM350230.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350230-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350231">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0023_Sepsis_day1_165</Title>
    <Accession database="GEO">GSM350231</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350231/suppl/GSM350231.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350231-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350232">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0024_Sepsis_day1_166</Title>
    <Accession database="GEO">GSM350232</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350232/suppl/GSM350232.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350232-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350233">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0044A_Sepsis_day1_174</Title>
    <Accession database="GEO">GSM350233</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350233/suppl/GSM350233.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617625" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350233-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350234">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0050A_Sepsis_day1_180</Title>
    <Accession database="GEO">GSM350234</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350234/suppl/GSM350234.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617626" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350234-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350235">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0006_Sepsis_day1_192</Title>
    <Accession database="GEO">GSM350235</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350235/suppl/GSM350235.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350235-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350236">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>15-0013A_Sepsis_day1_203</Title>
    <Accession database="GEO">GSM350236</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350236/suppl/GSM350236.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617627" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350236-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350237">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>15-0009A_Sepsis_day1_214</Title>
    <Accession database="GEO">GSM350237</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350237/suppl/GSM350237.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617628" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350237-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350238">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0002_Sepsis_day1_224</Title>
    <Accession database="GEO">GSM350238</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350238/suppl/GSM350238.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350238-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350239">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>12-0001_Sepsis_day1_228</Title>
    <Accession database="GEO">GSM350239</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350239/suppl/GSM350239.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350239-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350240">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0018_Sepsis_day3_25</Title>
    <Accession database="GEO">GSM350240</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350240/suppl/GSM350240.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350240-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350241">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0038B_Sepsis_day3_42</Title>
    <Accession database="GEO">GSM350241</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350241/suppl/GSM350241.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350241-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350242">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0050B_Sepsis_day3_50</Title>
    <Accession database="GEO">GSM350242</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350242/suppl/GSM350242.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350242-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350243">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>03-0001B_Sepsis_day3_63</Title>
    <Accession database="GEO">GSM350243</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350243/suppl/GSM350243.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350243-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350244">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>04-0002_Sepsis_day3_67</Title>
    <Accession database="GEO">GSM350244</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350244/suppl/GSM350244.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350244-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350245">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>07-0005_Sepsis_day3_98</Title>
    <Accession database="GEO">GSM350245</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350245/suppl/GSM350245.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350245-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350246">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>09-0001_Sepsis_day3_101</Title>
    <Accession database="GEO">GSM350246</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350246/suppl/GSM350246.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350246-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350247">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>10-0004_Sepsis_day3_112</Title>
    <Accession database="GEO">GSM350247</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350247/suppl/GSM350247.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350247-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350248">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0011_Sepsis_day3_119</Title>
    <Accession database="GEO">GSM350248</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350248/suppl/GSM350248.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350248-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350249">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>10-0012_Sepsis_day3_121</Title>
    <Accession database="GEO">GSM350249</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350249/suppl/GSM350249.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350249-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350250">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0028B_Sepsis_day3_128</Title>
    <Accession database="GEO">GSM350250</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350250/suppl/GSM350250.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350250-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350251">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0055B_Sepsis_day3_138</Title>
    <Accession database="GEO">GSM350251</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350251/suppl/GSM350251.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350251-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350252">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0057B_Sepsis_day3_139</Title>
    <Accession database="GEO">GSM350252</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350252/suppl/GSM350252.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350252-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350253">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0015_Sepsis_day3_154</Title>
    <Accession database="GEO">GSM350253</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350253/suppl/GSM350253.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350253-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350254">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0021_Sepsis_day3_163</Title>
    <Accession database="GEO">GSM350254</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350254/suppl/GSM350254.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350254-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350255">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0044B_Sepsis_day3_175</Title>
    <Accession database="GEO">GSM350255</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350255/suppl/GSM350255.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350255-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350256">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0050B_Sepsis_day3_181</Title>
    <Accession database="GEO">GSM350256</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350256/suppl/GSM350256.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350256-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350257">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0001_Sepsis_day3_189</Title>
    <Accession database="GEO">GSM350257</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350257/suppl/GSM350257.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350257-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350258">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>13-0005B_Sepsis_day3_190</Title>
    <Accession database="GEO">GSM350258</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350258/suppl/GSM350258.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350258-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350259">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>14-0002B_Sepsis_day3_196</Title>
    <Accession database="GEO">GSM350259</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Sepsis_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350259/suppl/GSM350259.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350259-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350260">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0007A_Septic Shock_day1_0</Title>
    <Accession database="GEO">GSM350260</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350260/suppl/GSM350260.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350260-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350261">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0034A_Septic Shock_day1_1</Title>
    <Accession database="GEO">GSM350261</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350261/suppl/GSM350261.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSM1617629" />
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350261-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350262">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0036A_Septic Shock_day1_3</Title>
    <Accession database="GEO">GSM350262</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350262/suppl/GSM350262.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350262-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350263">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0044A_Septic Shock_day1_9</Title>
    <Accession database="GEO">GSM350263</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350263/suppl/GSM350263.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350263-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350264">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0058A_Septic Shock_day1_10</Title>
    <Accession database="GEO">GSM350264</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350264/suppl/GSM350264.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350264-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350265">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0059A_Septic Shock_day1_12</Title>
    <Accession database="GEO">GSM350265</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350265/suppl/GSM350265.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350265-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350266">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0060A_Septic Shock_day1_14</Title>
    <Accession database="GEO">GSM350266</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350266/suppl/GSM350266.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350266-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350267">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0061A_Septic Shock_day1_15</Title>
    <Accession database="GEO">GSM350267</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350267/suppl/GSM350267.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350267-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350268">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0062A_Septic Shock_day1_17</Title>
    <Accession database="GEO">GSM350268</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350268/suppl/GSM350268.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350268-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350269">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0066A_Septic Shock_day1_21</Title>
    <Accession database="GEO">GSM350269</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350269/suppl/GSM350269.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350269-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350270">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0013_Septic Shock_day1_23</Title>
    <Accession database="GEO">GSM350270</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350270/suppl/GSM350270.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350270-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350271">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0014_Septic Shock_day1_24</Title>
    <Accession database="GEO">GSM350271</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350271/suppl/GSM350271.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350271-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350272">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0019_Septic Shock_day1_27</Title>
    <Accession database="GEO">GSM350272</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350272/suppl/GSM350272.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350272-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350273">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0021_Septic Shock_day1_28</Title>
    <Accession database="GEO">GSM350273</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350273/suppl/GSM350273.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350273-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350274">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0024_Septic Shock_day1_29</Title>
    <Accession database="GEO">GSM350274</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350274/suppl/GSM350274.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350274-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350275">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0025_Septic Shock_day1_31</Title>
    <Accession database="GEO">GSM350275</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350275/suppl/GSM350275.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350275-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350276">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0026_Septic Shock_day1_33</Title>
    <Accession database="GEO">GSM350276</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350276/suppl/GSM350276.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350276-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350277">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0030_Septic Shock_day1_37</Title>
    <Accession database="GEO">GSM350277</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350277/suppl/GSM350277.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350277-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350278">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0033A_Septic Shock_day1_39</Title>
    <Accession database="GEO">GSM350278</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350278/suppl/GSM350278.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350278-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350279">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0045A_Septic Shock_day1_43</Title>
    <Accession database="GEO">GSM350279</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350279/suppl/GSM350279.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350279-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350280">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0049A_Septic Shock_day1_48</Title>
    <Accession database="GEO">GSM350280</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350280/suppl/GSM350280.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350280-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350281">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0051A_Septic Shock_day1_52</Title>
    <Accession database="GEO">GSM350281</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350281/suppl/GSM350281.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350281-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350282">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0052A_Septic Shock_day1_54</Title>
    <Accession database="GEO">GSM350282</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350282/suppl/GSM350282.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350282-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350283">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0053A_Septic Shock_day1_55</Title>
    <Accession database="GEO">GSM350283</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350283/suppl/GSM350283.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350283-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350284">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>02-0001_Septic Shock_day1_59</Title>
    <Accession database="GEO">GSM350284</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350284/suppl/GSM350284.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350284-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350285">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>02-0002A_Septic Shock_day1_61</Title>
    <Accession database="GEO">GSM350285</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350285/suppl/GSM350285.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350285-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350286">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>04-0003_Septic Shock_day1_68</Title>
    <Accession database="GEO">GSM350286</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350286/suppl/GSM350286.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350286-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350287">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>04-0005_Septic Shock_day1_70</Title>
    <Accession database="GEO">GSM350287</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350287/suppl/GSM350287.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350287-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350288">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>05-0003_Septic Shock_day1_74</Title>
    <Accession database="GEO">GSM350288</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350288/suppl/GSM350288.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350288-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350289">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>05-0006_Septic Shock_day1_75</Title>
    <Accession database="GEO">GSM350289</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350289/suppl/GSM350289.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350289-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350290">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>05-0008_Septic Shock_day1_77</Title>
    <Accession database="GEO">GSM350290</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350290/suppl/GSM350290.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350290-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350291">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>05-0010_Septic Shock_day1_79</Title>
    <Accession database="GEO">GSM350291</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350291/suppl/GSM350291.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350291-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350292">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>05-0011_Septic Shock_day1_81</Title>
    <Accession database="GEO">GSM350292</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350292/suppl/GSM350292.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350292-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350293">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>06-0009A_Septic Shock_day1_83</Title>
    <Accession database="GEO">GSM350293</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350293/suppl/GSM350293.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350293-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350294">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>06-0001_Septic Shock_day1_85</Title>
    <Accession database="GEO">GSM350294</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350294/suppl/GSM350294.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350294-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350295">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>06-0003_Septic Shock_day1_88</Title>
    <Accession database="GEO">GSM350295</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350295/suppl/GSM350295.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350295-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350296">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>06-0004_Septic Shock_day1_90</Title>
    <Accession database="GEO">GSM350296</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350296/suppl/GSM350296.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350296-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350297">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>06-0006_Septic Shock_day1_92</Title>
    <Accession database="GEO">GSM350297</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350297/suppl/GSM350297.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350297-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350298">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>07-0002_Septic Shock_day1_95</Title>
    <Accession database="GEO">GSM350298</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350298/suppl/GSM350298.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350298-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350299">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>07-0006A_Septic Shock_day1_99</Title>
    <Accession database="GEO">GSM350299</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350299/suppl/GSM350299.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350299-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350300">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>09-0001_Septic Shock_day1_100</Title>
    <Accession database="GEO">GSM350300</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350300/suppl/GSM350300.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350300-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350301">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>09-0002_Septic Shock_day1_102</Title>
    <Accession database="GEO">GSM350301</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350301/suppl/GSM350301.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350301-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350302">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>10-0021A_Septic Shock_day1_104</Title>
    <Accession database="GEO">GSM350302</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350302/suppl/GSM350302.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350302-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350303">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0001_Septic Shock_day1_110</Title>
    <Accession database="GEO">GSM350303</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350303/suppl/GSM350303.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350303-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350304">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>10-0012_Septic Shock_day1_120</Title>
    <Accession database="GEO">GSM350304</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350304/suppl/GSM350304.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350304-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350305">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>10-0017_Septic Shock_day1_124</Title>
    <Accession database="GEO">GSM350305</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350305/suppl/GSM350305.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350305-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350306">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>10-0020_Septic Shock_day1_127</Title>
    <Accession database="GEO">GSM350306</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350306/suppl/GSM350306.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350306-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350307">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0001_Septic Shock_day1_142</Title>
    <Accession database="GEO">GSM350307</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350307/suppl/GSM350307.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350307-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350308">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0010_Septic Shock_day1_148</Title>
    <Accession database="GEO">GSM350308</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350308/suppl/GSM350308.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350308-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350309">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0017_Septic Shock_day1_157</Title>
    <Accession database="GEO">GSM350309</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350309/suppl/GSM350309.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350309-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350310">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0029_Septic Shock_day1_168</Title>
    <Accession database="GEO">GSM350310</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350310/suppl/GSM350310.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350310-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350311">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0054A_Septic Shock_day1_182</Title>
    <Accession database="GEO">GSM350311</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350311/suppl/GSM350311.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350311-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350312">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0057A_Septic Shock_day1_184</Title>
    <Accession database="GEO">GSM350312</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350312/suppl/GSM350312.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350312-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350313">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>12-0002A_Septic Shock_day1_188</Title>
    <Accession database="GEO">GSM350313</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350313/suppl/GSM350313.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350313-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350314">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>13-0002A_Septic Shock_day1_191</Title>
    <Accession database="GEO">GSM350314</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350314/suppl/GSM350314.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350314-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350315">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>14-0002A_Septic Shock_day1_195</Title>
    <Accession database="GEO">GSM350315</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350315/suppl/GSM350315.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350315-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350316">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>14-0004A_Septic Shock_day1_197</Title>
    <Accession database="GEO">GSM350316</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350316/suppl/GSM350316.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350316-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350317">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>15-0011A_Septic Shock_day1_201</Title>
    <Accession database="GEO">GSM350317</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350317/suppl/GSM350317.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350317-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350318">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>15-0012A_Septic Shock_day1_202</Title>
    <Accession database="GEO">GSM350318</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350318/suppl/GSM350318.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350318-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350319">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>15-0004_Septic Shock_day1_207</Title>
    <Accession database="GEO">GSM350319</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350319/suppl/GSM350319.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350319-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350320">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>15-0007_Septic Shock_day1_210</Title>
    <Accession database="GEO">GSM350320</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350320/suppl/GSM350320.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350320-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350321">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>15-0008_Septic Shock_day1_212</Title>
    <Accession database="GEO">GSM350321</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350321/suppl/GSM350321.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350321-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350322">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>17-0001A_Septic Shock_day1_216</Title>
    <Accession database="GEO">GSM350322</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350322/suppl/GSM350322.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350322-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350323">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>04-0004_Septic Shock_day1_219</Title>
    <Accession database="GEO">GSM350323</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350323/suppl/GSM350323.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350323-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350324">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>26-260611_Septic Shock_day1_222</Title>
    <Accession database="GEO">GSM350324</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350324/suppl/GSM350324.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350324-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350325">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>25-070603_Septic Shock_day1_223</Title>
    <Accession database="GEO">GSM350325</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350325/suppl/GSM350325.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350325-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350326">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>05-0007_Septic Shock_day1_226</Title>
    <Accession database="GEO">GSM350326</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350326/suppl/GSM350326.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350326-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350327">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0034B_Septic Shock_day3_2</Title>
    <Accession database="GEO">GSM350327</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350327/suppl/GSM350327.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350327-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350328">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0058B_Septic Shock_day3_11</Title>
    <Accession database="GEO">GSM350328</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350328/suppl/GSM350328.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350328-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350329">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0061B_Septic Shock_day3_16</Title>
    <Accession database="GEO">GSM350329</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350329/suppl/GSM350329.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350329-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350330">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0062B_Septic Shock_day3_18</Title>
    <Accession database="GEO">GSM350330</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350330/suppl/GSM350330.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350330-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350331">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0066B_Septic Shock_day3_22</Title>
    <Accession database="GEO">GSM350331</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350331/suppl/GSM350331.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350331-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350332">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0019_Septic Shock_day3_26</Title>
    <Accession database="GEO">GSM350332</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350332/suppl/GSM350332.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350332-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350333">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0025_Septic Shock_day3_32</Title>
    <Accession database="GEO">GSM350333</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350333/suppl/GSM350333.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350333-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350334">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>01-0030_Septic Shock_day3_38</Title>
    <Accession database="GEO">GSM350334</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350334/suppl/GSM350334.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350334-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350335">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0036B_Septic Shock_day3_40</Title>
    <Accession database="GEO">GSM350335</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350335/suppl/GSM350335.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350335-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350336">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0045B_Septic Shock_day3_44</Title>
    <Accession database="GEO">GSM350336</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350336/suppl/GSM350336.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350336-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350337">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0049B_Septic Shock_day3_47</Title>
    <Accession database="GEO">GSM350337</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350337/suppl/GSM350337.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350337-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350338">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0051B_Septic Shock_day3_53</Title>
    <Accession database="GEO">GSM350338</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350338/suppl/GSM350338.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350338-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350339">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0053B_Septic Shock_day3_56</Title>
    <Accession database="GEO">GSM350339</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350339/suppl/GSM350339.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350339-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350340">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0055B_Septic Shock_day3_58</Title>
    <Accession database="GEO">GSM350340</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350340/suppl/GSM350340.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350340-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350341">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>02-0002B_Septic Shock_day3_62</Title>
    <Accession database="GEO">GSM350341</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350341/suppl/GSM350341.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350341-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350342">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>04-0003_Septic Shock_day3_69</Title>
    <Accession database="GEO">GSM350342</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350342/suppl/GSM350342.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350342-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350343">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>05-0006_Septic Shock_day3_76</Title>
    <Accession database="GEO">GSM350343</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350343/suppl/GSM350343.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350343-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350344">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>05-0010_Septic Shock_day3_80</Title>
    <Accession database="GEO">GSM350344</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350344/suppl/GSM350344.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350344-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350345">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>05-0014B_Septic Shock_day3_82</Title>
    <Accession database="GEO">GSM350345</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350345/suppl/GSM350345.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350345-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350346">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>06-0009B_Septic Shock_day3_84</Title>
    <Accession database="GEO">GSM350346</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350346/suppl/GSM350346.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350346-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350347">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>06-0003_Septic Shock_day3_89</Title>
    <Accession database="GEO">GSM350347</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350347/suppl/GSM350347.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350347-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350348">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>06-0004_Septic Shock_day3_91</Title>
    <Accession database="GEO">GSM350348</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350348/suppl/GSM350348.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350348-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350349">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>06-0006_Septic Shock_day3_93</Title>
    <Accession database="GEO">GSM350349</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350349/suppl/GSM350349.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350349-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350350">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>07-0001_Septic Shock_day3_94</Title>
    <Accession database="GEO">GSM350350</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350350/suppl/GSM350350.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350350-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350351">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>09-0002_Septic Shock_day3_103</Title>
    <Accession database="GEO">GSM350351</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350351/suppl/GSM350351.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350351-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350352">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>10-0013_Septic Shock_day3_122</Title>
    <Accession database="GEO">GSM350352</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350352/suppl/GSM350352.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350352-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350353">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>10-0017_Septic Shock_day3_125</Title>
    <Accession database="GEO">GSM350353</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350353/suppl/GSM350353.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350353-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350354">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>10-0020_Septic Shock_day3_126</Title>
    <Accession database="GEO">GSM350354</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350354/suppl/GSM350354.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350354-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350355">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0017_Septic Shock_day3_158</Title>
    <Accession database="GEO">GSM350355</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350355/suppl/GSM350355.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350355-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350356">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>11-0029_Septic Shock_day3_169</Title>
    <Accession database="GEO">GSM350356</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350356/suppl/GSM350356.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350356-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350357">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>11-0054B_Septic Shock_day3_183</Title>
    <Accession database="GEO">GSM350357</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350357/suppl/GSM350357.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350357-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350358">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>15-0004_Septic Shock_day3_208</Title>
    <Accession database="GEO">GSM350358</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350358/suppl/GSM350358.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350358-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350359">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>15-0007_Septic Shock_day3_211</Title>
    <Accession database="GEO">GSM350359</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350359/suppl/GSM350359.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350359-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350360">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>15-0008_Septic Shock_day3_213</Title>
    <Accession database="GEO">GSM350360</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350360/suppl/GSM350360.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350360-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350361">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>17-0003B_Septic Shock_day3_215</Title>
    <Accession database="GEO">GSM350361</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350361/suppl/GSM350361.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350361-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350362">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>17-0001B_Septic Shock_day3_217</Title>
    <Accession database="GEO">GSM350362</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350362/suppl/GSM350362.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350362-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350363">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2018-08-28</Last-Update-Date>
    </Status>
    <Title>01-0022_Septic Shock_day3_218</Title>
    <Accession database="GEO">GSM350363</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350363/suppl/GSM350363.CEL.gz
    </Supplementary-Data>
    <Relation type="Reanalyzed by" target="GSE119087" />
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350363-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350364">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>04-0004_Septic Shock_day3_220</Title>
    <Accession database="GEO">GSM350364</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350364/suppl/GSM350364.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350364-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM350365">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2009-03-18</Last-Update-Date>
    </Status>
    <Title>05-0007_Septic Shock_day3_227</Title>
    <Accession database="GEO">GSM350365</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Septic Shock_day3</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics>
Whole blood from normal children and children with SIRS, sepsis, or septic shock.
      </Characteristics>
      <Treatment-Protocol>
Samples were not manipulated.
      </Treatment-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted from whole blood using the PaxGene protocol.
Quality control steps: Total RNA was purified using RNeasy columns [Qiagen, Valencia, CA] according to the manufacturer’s directions and quality was assessed using an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc., Palo Alto, CA].
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
120 ng of total RNA from 2 wild type [WT] and 4 beta-catenin knock-out [KO] pancreata at the 14.5 and 16.5 time points was amplified twice with the Arcturus RiboAmp kit [Arcturus Bioscience, Inc., Mountain View, CA] and cRNA was labeled with biotin-UTP, CTP using T7 RNA polymerase [Enzo Life Sciences, Inc., Farmingdale, NY].
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Create a hybridization cocktail for a single probe array that contains 0.05 ug/uL fragmented cRNA, 50 pM Control Oligonucleotide B2 (Affymetrix), 20X Eukaryotic Hybridization Controls (1.5 pM bioB, 5 pM bioC, 25 pM bioD, 100 pM cre) (Affymetrix), 0.1 mg/mL Herring Sperm DNA (Promega), 0.5 mg/mL Acetylated BSA (Invitrogen), and 1X Hybridization Buffer. Heat hybridization cocktail to 99°C for 5 minutes, to 45°C for 5 minutes, and spin at maximum speed in a microcentrifuge for 5 minutes. Fill probe array with 200 uL of 1X Hybridization Buffer. Incubate at 45°C for 10 minutes in the GeneChip Hybridization Oven 640 (Affymetrix) rotating at 60 rpm. Remove 1X Hybridization Buffer and fill probe array with 200 uL of the hybridization cocktail. Incubate at 45°C for 16 hrs in the Hybridization Oven rotating at 60 rpm.
Fluidics:  Wash and Stain probe arrays using the Fluidics Station 450 (Affymetrix) utilizing the fluidics protocol EukGE-WS2v5_450. Arrays were stained with phycoerythrin-conjugated streptavidin [Molecular Probes, Eugene, OR] and hybridization signals were amplified using antibody amplification with goat IgG [Sigma-Aldrich] and anti-streptavidin biotinylated antibody [Vector Laboratories, Burlingame, CA], as described in the Affymetrix GeneChip® Expression Analysis Manual.
    </Hybridization-Protocol>
    <Scan-Protocol>
Images were scanned using a Genechip scanner 3000 [Affymetrix]
    </Scan-Protocol>
    <Description>
1) Controls: 2) Septic shock; 3) Sepsis; 4) SIRS; 5) SIRS resolved
    </Description>
    <Data-Processing>
Commercial Affymetrix Human Genome U133 Plus 2.0 GeneChip (Affymetrix, Santa Clara, CA). GeneChip CEL  files were subjected to RMA  normalization using  the  GeneSpring GX 7.1.
Standard Affymetrix internal control genes were used to check the quality of the assay by the signals of the 3' probe set to the 5' probe set of the internal control genes, GAPDH and beta-actin, with acceptable 3' to 5' ratios between 1 and 3. Eukaryotic Spike controls were used to determine that the hybridization of target RNA to the array occurred properly.
GeneSpring 7.2 (Agilent technologies Inc. Palo Alto, California) was used for normalization, clustering, filtering, and statistical analyses. The Raw CEL files were processed using the RMA (Robust Multichip Average) built in GeneSpring software. All the samples were then normalized to the median of the controls.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM350nnn/GSM350365/suppl/GSM350365.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized to mean of controls</Description>
      </Column>
    <External-Data rows="54675">
GSM350365-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Series iid="GSE13904">
    <Status database="GEO">
      <Submission-Date>2008-12-10</Submission-Date>
      <Release-Date>2008-12-12</Release-Date>
      <Last-Update-Date>2019-03-25</Last-Update-Date>
    </Status>
    <Title>Expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum</Title>
    <Accession database="GEO">GSE13904</Accession>
    <Pubmed-ID>19325468</Pubmed-ID>
    <Summary>
Normal children, children with SIRS, children with sepsis, and children with septic shock.

Objectives: To advance our biological understanding of pediatric septic shock, we measured the genome-level expression profiles of critically ill children representing the systemic inflammatory response syndrome (SIRS), sepsis, and septic shock spectrum.
Keywords: Normal vs diseased
    </Summary>
    <Overall-Design>
Prospective observational study involving microarray-based bioinformatics.
    </Overall-Design>
    <Type>Expression profiling by array</Type>
    <Contributor-Ref ref="contrib1" position="1" />
    <Contributor-Ref ref="contrib3" position="2" />
    <Contributor-Ref ref="contrib4" position="3" />
    <Contributor-Ref ref="contrib5" position="4" />
    <Contributor-Ref ref="contrib6" position="5" />
    <Contributor-Ref ref="contrib7" position="6" />
    <Contributor-Ref ref="contrib8" position="7" />
    <Contributor-Ref ref="contrib9" position="8" />
    <Contributor-Ref ref="contrib10" position="9" />
    <Contributor-Ref ref="contrib11" position="10" />
    <Contributor-Ref ref="contrib12" position="11" />
    <Contact-Ref ref="contrib1" />
    <Sample-Ref ref="GSM350139" />
    <Sample-Ref ref="GSM350140" />
    <Sample-Ref ref="GSM350141" />
    <Sample-Ref ref="GSM350142" />
    <Sample-Ref ref="GSM350143" />
    <Sample-Ref ref="GSM350144" />
    <Sample-Ref ref="GSM350145" />
    <Sample-Ref ref="GSM350146" />
    <Sample-Ref ref="GSM350147" />
    <Sample-Ref ref="GSM350148" />
    <Sample-Ref ref="GSM350149" />
    <Sample-Ref ref="GSM350150" />
    <Sample-Ref ref="GSM350151" />
    <Sample-Ref ref="GSM350152" />
    <Sample-Ref ref="GSM350153" />
    <Sample-Ref ref="GSM350154" />
    <Sample-Ref ref="GSM350155" />
    <Sample-Ref ref="GSM350156" />
    <Sample-Ref ref="GSM350157" />
    <Sample-Ref ref="GSM350158" />
    <Sample-Ref ref="GSM350159" />
    <Sample-Ref ref="GSM350160" />
    <Sample-Ref ref="GSM350161" />
    <Sample-Ref ref="GSM350162" />
    <Sample-Ref ref="GSM350163" />
    <Sample-Ref ref="GSM350164" />
    <Sample-Ref ref="GSM350165" />
    <Sample-Ref ref="GSM350166" />
    <Sample-Ref ref="GSM350167" />
    <Sample-Ref ref="GSM350168" />
    <Sample-Ref ref="GSM350169" />
    <Sample-Ref ref="GSM350170" />
    <Sample-Ref ref="GSM350171" />
    <Sample-Ref ref="GSM350172" />
    <Sample-Ref ref="GSM350173" />
    <Sample-Ref ref="GSM350174" />
    <Sample-Ref ref="GSM350175" />
    <Sample-Ref ref="GSM350176" />
    <Sample-Ref ref="GSM350177" />
    <Sample-Ref ref="GSM350178" />
    <Sample-Ref ref="GSM350179" />
    <Sample-Ref ref="GSM350180" />
    <Sample-Ref ref="GSM350181" />
    <Sample-Ref ref="GSM350182" />
    <Sample-Ref ref="GSM350183" />
    <Sample-Ref ref="GSM350184" />
    <Sample-Ref ref="GSM350185" />
    <Sample-Ref ref="GSM350186" />
    <Sample-Ref ref="GSM350187" />
    <Sample-Ref ref="GSM350188" />
    <Sample-Ref ref="GSM350189" />
    <Sample-Ref ref="GSM350190" />
    <Sample-Ref ref="GSM350191" />
    <Sample-Ref ref="GSM350192" />
    <Sample-Ref ref="GSM350193" />
    <Sample-Ref ref="GSM350194" />
    <Sample-Ref ref="GSM350195" />
    <Sample-Ref ref="GSM350196" />
    <Sample-Ref ref="GSM350197" />
    <Sample-Ref ref="GSM350198" />
    <Sample-Ref ref="GSM350199" />
    <Sample-Ref ref="GSM350200" />
    <Sample-Ref ref="GSM350201" />
    <Sample-Ref ref="GSM350202" />
    <Sample-Ref ref="GSM350203" />
    <Sample-Ref ref="GSM350204" />
    <Sample-Ref ref="GSM350205" />
    <Sample-Ref ref="GSM350206" />
    <Sample-Ref ref="GSM350207" />
    <Sample-Ref ref="GSM350208" />
    <Sample-Ref ref="GSM350209" />
    <Sample-Ref ref="GSM350210" />
    <Sample-Ref ref="GSM350211" />
    <Sample-Ref ref="GSM350212" />
    <Sample-Ref ref="GSM350213" />
    <Sample-Ref ref="GSM350214" />
    <Sample-Ref ref="GSM350215" />
    <Sample-Ref ref="GSM350216" />
    <Sample-Ref ref="GSM350217" />
    <Sample-Ref ref="GSM350218" />
    <Sample-Ref ref="GSM350219" />
    <Sample-Ref ref="GSM350220" />
    <Sample-Ref ref="GSM350221" />
    <Sample-Ref ref="GSM350222" />
    <Sample-Ref ref="GSM350223" />
    <Sample-Ref ref="GSM350224" />
    <Sample-Ref ref="GSM350225" />
    <Sample-Ref ref="GSM350226" />
    <Sample-Ref ref="GSM350227" />
    <Sample-Ref ref="GSM350228" />
    <Sample-Ref ref="GSM350229" />
    <Sample-Ref ref="GSM350230" />
    <Sample-Ref ref="GSM350231" />
    <Sample-Ref ref="GSM350232" />
    <Sample-Ref ref="GSM350233" />
    <Sample-Ref ref="GSM350234" />
    <Sample-Ref ref="GSM350235" />
    <Sample-Ref ref="GSM350236" />
    <Sample-Ref ref="GSM350237" />
    <Sample-Ref ref="GSM350238" />
    <Sample-Ref ref="GSM350239" />
    <Sample-Ref ref="GSM350240" />
    <Sample-Ref ref="GSM350241" />
    <Sample-Ref ref="GSM350242" />
    <Sample-Ref ref="GSM350243" />
    <Sample-Ref ref="GSM350244" />
    <Sample-Ref ref="GSM350245" />
    <Sample-Ref ref="GSM350246" />
    <Sample-Ref ref="GSM350247" />
    <Sample-Ref ref="GSM350248" />
    <Sample-Ref ref="GSM350249" />
    <Sample-Ref ref="GSM350250" />
    <Sample-Ref ref="GSM350251" />
    <Sample-Ref ref="GSM350252" />
    <Sample-Ref ref="GSM350253" />
    <Sample-Ref ref="GSM350254" />
    <Sample-Ref ref="GSM350255" />
    <Sample-Ref ref="GSM350256" />
    <Sample-Ref ref="GSM350257" />
    <Sample-Ref ref="GSM350258" />
    <Sample-Ref ref="GSM350259" />
    <Sample-Ref ref="GSM350260" />
    <Sample-Ref ref="GSM350261" />
    <Sample-Ref ref="GSM350262" />
    <Sample-Ref ref="GSM350263" />
    <Sample-Ref ref="GSM350264" />
    <Sample-Ref ref="GSM350265" />
    <Sample-Ref ref="GSM350266" />
    <Sample-Ref ref="GSM350267" />
    <Sample-Ref ref="GSM350268" />
    <Sample-Ref ref="GSM350269" />
    <Sample-Ref ref="GSM350270" />
    <Sample-Ref ref="GSM350271" />
    <Sample-Ref ref="GSM350272" />
    <Sample-Ref ref="GSM350273" />
    <Sample-Ref ref="GSM350274" />
    <Sample-Ref ref="GSM350275" />
    <Sample-Ref ref="GSM350276" />
    <Sample-Ref ref="GSM350277" />
    <Sample-Ref ref="GSM350278" />
    <Sample-Ref ref="GSM350279" />
    <Sample-Ref ref="GSM350280" />
    <Sample-Ref ref="GSM350281" />
    <Sample-Ref ref="GSM350282" />
    <Sample-Ref ref="GSM350283" />
    <Sample-Ref ref="GSM350284" />
    <Sample-Ref ref="GSM350285" />
    <Sample-Ref ref="GSM350286" />
    <Sample-Ref ref="GSM350287" />
    <Sample-Ref ref="GSM350288" />
    <Sample-Ref ref="GSM350289" />
    <Sample-Ref ref="GSM350290" />
    <Sample-Ref ref="GSM350291" />
    <Sample-Ref ref="GSM350292" />
    <Sample-Ref ref="GSM350293" />
    <Sample-Ref ref="GSM350294" />
    <Sample-Ref ref="GSM350295" />
    <Sample-Ref ref="GSM350296" />
    <Sample-Ref ref="GSM350297" />
    <Sample-Ref ref="GSM350298" />
    <Sample-Ref ref="GSM350299" />
    <Sample-Ref ref="GSM350300" />
    <Sample-Ref ref="GSM350301" />
    <Sample-Ref ref="GSM350302" />
    <Sample-Ref ref="GSM350303" />
    <Sample-Ref ref="GSM350304" />
    <Sample-Ref ref="GSM350305" />
    <Sample-Ref ref="GSM350306" />
    <Sample-Ref ref="GSM350307" />
    <Sample-Ref ref="GSM350308" />
    <Sample-Ref ref="GSM350309" />
    <Sample-Ref ref="GSM350310" />
    <Sample-Ref ref="GSM350311" />
    <Sample-Ref ref="GSM350312" />
    <Sample-Ref ref="GSM350313" />
    <Sample-Ref ref="GSM350314" />
    <Sample-Ref ref="GSM350315" />
    <Sample-Ref ref="GSM350316" />
    <Sample-Ref ref="GSM350317" />
    <Sample-Ref ref="GSM350318" />
    <Sample-Ref ref="GSM350319" />
    <Sample-Ref ref="GSM350320" />
    <Sample-Ref ref="GSM350321" />
    <Sample-Ref ref="GSM350322" />
    <Sample-Ref ref="GSM350323" />
    <Sample-Ref ref="GSM350324" />
    <Sample-Ref ref="GSM350325" />
    <Sample-Ref ref="GSM350326" />
    <Sample-Ref ref="GSM350327" />
    <Sample-Ref ref="GSM350328" />
    <Sample-Ref ref="GSM350329" />
    <Sample-Ref ref="GSM350330" />
    <Sample-Ref ref="GSM350331" />
    <Sample-Ref ref="GSM350332" />
    <Sample-Ref ref="GSM350333" />
    <Sample-Ref ref="GSM350334" />
    <Sample-Ref ref="GSM350335" />
    <Sample-Ref ref="GSM350336" />
    <Sample-Ref ref="GSM350337" />
    <Sample-Ref ref="GSM350338" />
    <Sample-Ref ref="GSM350339" />
    <Sample-Ref ref="GSM350340" />
    <Sample-Ref ref="GSM350341" />
    <Sample-Ref ref="GSM350342" />
    <Sample-Ref ref="GSM350343" />
    <Sample-Ref ref="GSM350344" />
    <Sample-Ref ref="GSM350345" />
    <Sample-Ref ref="GSM350346" />
    <Sample-Ref ref="GSM350347" />
    <Sample-Ref ref="GSM350348" />
    <Sample-Ref ref="GSM350349" />
    <Sample-Ref ref="GSM350350" />
    <Sample-Ref ref="GSM350351" />
    <Sample-Ref ref="GSM350352" />
    <Sample-Ref ref="GSM350353" />
    <Sample-Ref ref="GSM350354" />
    <Sample-Ref ref="GSM350355" />
    <Sample-Ref ref="GSM350356" />
    <Sample-Ref ref="GSM350357" />
    <Sample-Ref ref="GSM350358" />
    <Sample-Ref ref="GSM350359" />
    <Sample-Ref ref="GSM350360" />
    <Sample-Ref ref="GSM350361" />
    <Sample-Ref ref="GSM350362" />
    <Sample-Ref ref="GSM350363" />
    <Sample-Ref ref="GSM350364" />
    <Sample-Ref ref="GSM350365" />
    <Supplementary-Data type="TAR">
ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE13nnn/GSE13904/suppl/GSE13904_RAW.tar
    </Supplementary-Data>
    <Supplementary-Data type="PDF">
ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE13nnn/GSE13904/suppl/GSE13904_WongEtAl_2008_MIAMI.pdf
    </Supplementary-Data>
    <Relation type="BioProject" target="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA110317" />
  </Series>

</MINiML>
